Finance

Lists
Why is 544619 down 4,89%?
Dive Deeper
544619:BOM
Sudeep Pharma Ltd
₹1 005,10
-4,89%
(-51,65) 1D
15 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 544619...
Open
₹1 032,45
High
₹1 062,85
Low
₹1 005,00
Mkt. cap
114,30 mjd
Avg. vol.
19,05 k
Volume
15,14 k
Dividend
0,15%
Quarterly dividend
₹0,37
Ex-dividend date
23 Jul. 2026
P/E ratio
61,89
52-wk high
₹1 376,00
52-wk low
₹524,95
EPS
₹16,24
No. of employees
525
Open
₹1 032,45
High
₹1 062,85
Low
₹1 005,00
Mkt. cap
114,30 mjd
Avg. vol.
19,05 k
Volume
15,14 k
Dividend
0,15%
Quarterly dividend
₹0,37
Ex-dividend date
23 Jul. 2026
P/E ratio
61,89
52-wk high
₹1 376,00
52-wk low
₹524,95
EPS
₹16,24
No. of employees
525
News stories
From web sources and news partners
About Sudeep Pharma Ltd
CEO-
Employees525
Founded1989
Headquarters-
SectorSpeciality chemicals
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,63 mjd
1,72 mjd
1,82 mjd
1,58 mjd
Cost of goods sold
609,35 m
601,93 m
674,88 m
565,91 m
Cost of revenue
609,35 m
601,93 m
674,88 m
565,91 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
140,95 m
150,37 m
153,34 m
143,40 m
Operating expense
500,81 m
560,33 m
561,40 m
507,69 m
Total operating expenses
1,11 mjd
1,16 mjd
1,24 mjd
1,07 mjd
Operating income
516,50 m
561,10 m
587,11 m
509,10 m
Other non operating income
101,66 m
68,37 m
-224,91 m
54,45 m
EBT including unusual items
595,34 m
617,76 m
626,93 m
542,93 m
EBT excluding unusual items
595,34 m
617,76 m
616,16 m
542,93 m
Income tax expense
127,56 m
140,77 m
141,55 m
137,06 m
Effective tax rate
21,43%
22,79%
22,58%
25,24%
Other operating expenses
321,74 m
371,34 m
366,92 m
324,29 m
Net income
457,47 m
474,62 m
488,77 m
405,50 m
Net profit margin
28,12%
27,54%
26,81%
25,62%
Earnings per share
-
-
4,38
3,59
Interest and investment income
-
-
33,79 m
-
Interest expense
-22,82 m
-11,71 m
-19,39 m
-20,63 m
Net interest expenses
-22,82 m
-11,71 m
14,40 m
-20,63 m
Depreciation and amortization charges
38,11 m
38,61 m
38,84 m
40,01 m
EBITDA
556,94 m
601,54 m
621,58 m
543,57 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme